Increased neuropilin-1 expression by COVID-19: a possible cause of long-term neurological complications and progression of primary brain tumors
Hum Cell
.
2022 Jul;35(4):1301-1303.
doi: 10.1007/s13577-022-00716-2.
Epub 2022 May 9.
Authors
Hamidreza Zalpoor
1
2
3
,
Hooriyeh Shapourian
4
,
Abdullatif Akbari
5
6
,
Shaghayegh Shahveh
7
,
Leila Haghshenas
8
Affiliations
1
Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. hamidreza.zlpr1998@gmail.com.
2
Network of Immunity in Infection, Malignancy & Autoimmunity (NIIMA), Universal Scientific Education & Research Network (USERN), Tehran, Iran. hamidreza.zlpr1998@gmail.com.
3
American Association of Kidney Patients, Tampa, FL, USA. hamidreza.zlpr1998@gmail.com.
4
Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
5
Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
6
Network of Immunity in Infection, Malignancy & Autoimmunity (NIIMA), Universal Scientific Education & Research Network (USERN), Tehran, Iran.
7
American Association of Naturopath Physician (AANP), Washington, DC, USA.
8
PhD, Postdoc Association Member of Harvard Medical School, Boston, MA, USA.
PMID:
35534753
PMCID:
PMC9084541
DOI:
10.1007/s13577-022-00716-2
No abstract available
Publication types
Letter
MeSH terms
Brain Neoplasms*
COVID-19* / complications
Humans
Neuropilin-1 / genetics
Vascular Endothelial Growth Factor A / metabolism
Substances
Vascular Endothelial Growth Factor A
Neuropilin-1